nodes	percent_of_prediction	percent_of_DWPC	metapath
Abacavir—UGT1A1—Etoposide—uterine cancer	0.338	1	CbGbCtD
Abacavir—ADH6—renal system—uterine cancer	0.0347	0.28	CbGeAlD
Abacavir—Cladribine—RRM2—uterine cancer	0.013	1	CrCbGaD
Abacavir—ADK—myometrium—uterine cancer	0.011	0.0891	CbGeAlD
Abacavir—ADK—uterine cervix—uterine cancer	0.00859	0.0693	CbGeAlD
Abacavir—ADK—smooth muscle tissue—uterine cancer	0.00835	0.0673	CbGeAlD
Abacavir—ADK—decidua—uterine cancer	0.00819	0.066	CbGeAlD
Abacavir—ADK—renal system—uterine cancer	0.00804	0.0648	CbGeAlD
Abacavir—UGT1A1—renal system—uterine cancer	0.00793	0.064	CbGeAlD
Abacavir—ADK—endometrium—uterine cancer	0.00777	0.0627	CbGeAlD
Abacavir—ADK—mammalian vulva—uterine cancer	0.00752	0.0606	CbGeAlD
Abacavir—ADK—female reproductive system—uterine cancer	0.00644	0.0519	CbGeAlD
Abacavir—ADK—female gonad—uterine cancer	0.00586	0.0472	CbGeAlD
Abacavir—ADK—vagina—uterine cancer	0.00582	0.047	CbGeAlD
Abacavir—ADK—lymph node—uterine cancer	0.00377	0.0304	CbGeAlD
Abacavir—ADH6—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.00126	0.135	CbGpPWpGaD
Abacavir—Stomatitis—Etoposide—uterine cancer	0.00115	0.00222	CcSEcCtD
Abacavir—Creatinine increased—Doxorubicin—uterine cancer	0.00114	0.00222	CcSEcCtD
Abacavir—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.00114	0.00222	CcSEcCtD
Abacavir—Malaise—Dactinomycin—uterine cancer	0.00114	0.00222	CcSEcCtD
Abacavir—Influenza like illness—Epirubicin—uterine cancer	0.00114	0.00222	CcSEcCtD
Abacavir—Leukopenia—Dactinomycin—uterine cancer	0.00114	0.0022	CcSEcCtD
Abacavir—Inflammation—Doxorubicin—uterine cancer	0.00112	0.00218	CcSEcCtD
Abacavir—Hepatobiliary disease—Etoposide—uterine cancer	0.00111	0.00215	CcSEcCtD
Abacavir—Aplastic anaemia—Epirubicin—uterine cancer	0.00111	0.00214	CcSEcCtD
Abacavir—Neuropathy—Epirubicin—uterine cancer	0.00111	0.00214	CcSEcCtD
Abacavir—Musculoskeletal pain—Doxorubicin—uterine cancer	0.0011	0.00214	CcSEcCtD
Abacavir—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.00109	0.00212	CcSEcCtD
Abacavir—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.00109	0.0021	CcSEcCtD
Abacavir—Myalgia—Dactinomycin—uterine cancer	0.00108	0.00209	CcSEcCtD
Abacavir—Hypersensitivity—Progesterone—uterine cancer	0.00108	0.00209	CcSEcCtD
Abacavir—Abnormal dreams—Doxorubicin—uterine cancer	0.00108	0.00209	CcSEcCtD
Abacavir—Discomfort—Dactinomycin—uterine cancer	0.00107	0.00207	CcSEcCtD
Abacavir—Mouth ulceration—Epirubicin—uterine cancer	0.00106	0.00206	CcSEcCtD
Abacavir—Influenza like illness—Doxorubicin—uterine cancer	0.00106	0.00205	CcSEcCtD
Abacavir—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.00105	0.00204	CcSEcCtD
Abacavir—Asthenia—Progesterone—uterine cancer	0.00105	0.00204	CcSEcCtD
Abacavir—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.00105	0.00203	CcSEcCtD
Abacavir—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.00105	0.00203	CcSEcCtD
Abacavir—Pruritus—Progesterone—uterine cancer	0.00104	0.00201	CcSEcCtD
Abacavir—Oedema—Dactinomycin—uterine cancer	0.00104	0.00201	CcSEcCtD
Abacavir—Infection—Dactinomycin—uterine cancer	0.00103	0.00199	CcSEcCtD
Abacavir—Aplastic anaemia—Doxorubicin—uterine cancer	0.00102	0.00198	CcSEcCtD
Abacavir—Neuropathy—Doxorubicin—uterine cancer	0.00102	0.00198	CcSEcCtD
Abacavir—Thrombocytopenia—Dactinomycin—uterine cancer	0.00101	0.00197	CcSEcCtD
Abacavir—Diarrhoea—Progesterone—uterine cancer	0.001	0.00194	CcSEcCtD
Abacavir—Lymphadenopathy—Epirubicin—uterine cancer	0.001	0.00194	CcSEcCtD
Abacavir—Erythema multiforme—Etoposide—uterine cancer	0.000998	0.00193	CcSEcCtD
Abacavir—Anorexia—Dactinomycin—uterine cancer	0.000987	0.00191	CcSEcCtD
Abacavir—Mouth ulceration—Doxorubicin—uterine cancer	0.000985	0.00191	CcSEcCtD
Abacavir—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000978	0.0019	CcSEcCtD
Abacavir—Dizziness—Progesterone—uterine cancer	0.000969	0.00188	CcSEcCtD
Abacavir—Immune system disorder—Etoposide—uterine cancer	0.000953	0.00185	CcSEcCtD
Abacavir—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000953	0.00185	CcSEcCtD
Abacavir—Hepatic failure—Epirubicin—uterine cancer	0.000951	0.00184	CcSEcCtD
Abacavir—Chills—Etoposide—uterine cancer	0.000947	0.00183	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000944	0.00183	CcSEcCtD
Abacavir—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000939	0.00182	CcSEcCtD
Abacavir—Alopecia—Etoposide—uterine cancer	0.000932	0.00181	CcSEcCtD
Abacavir—Vomiting—Progesterone—uterine cancer	0.000932	0.00181	CcSEcCtD
Abacavir—Lymphadenopathy—Doxorubicin—uterine cancer	0.000927	0.0018	CcSEcCtD
Abacavir—ADH6—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000924	0.099	CbGpPWpGaD
Abacavir—Rash—Progesterone—uterine cancer	0.000924	0.00179	CcSEcCtD
Abacavir—Dermatitis—Progesterone—uterine cancer	0.000923	0.00179	CcSEcCtD
Abacavir—Headache—Progesterone—uterine cancer	0.000918	0.00178	CcSEcCtD
Abacavir—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000909	0.00176	CcSEcCtD
Abacavir—Decreased appetite—Dactinomycin—uterine cancer	0.0009	0.00175	CcSEcCtD
Abacavir—Fatigue—Dactinomycin—uterine cancer	0.000893	0.00173	CcSEcCtD
Abacavir—Pain—Dactinomycin—uterine cancer	0.000886	0.00172	CcSEcCtD
Abacavir—Hepatic failure—Doxorubicin—uterine cancer	0.00088	0.00171	CcSEcCtD
Abacavir—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000878	0.0017	CcSEcCtD
Abacavir—Lethargy—Epirubicin—uterine cancer	0.000872	0.00169	CcSEcCtD
Abacavir—Nausea—Progesterone—uterine cancer	0.00087	0.00169	CcSEcCtD
Abacavir—Feeling abnormal—Dactinomycin—uterine cancer	0.000854	0.00165	CcSEcCtD
Abacavir—Ill-defined disorder—Etoposide—uterine cancer	0.000852	0.00165	CcSEcCtD
Abacavir—Anaemia—Etoposide—uterine cancer	0.000849	0.00165	CcSEcCtD
Abacavir—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000847	0.00164	CcSEcCtD
Abacavir—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000844	0.00164	CcSEcCtD
Abacavir—Migraine—Epirubicin—uterine cancer	0.000842	0.00163	CcSEcCtD
Abacavir—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000837	0.00162	CcSEcCtD
Abacavir—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000836	0.00162	CcSEcCtD
Abacavir—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000832	0.00161	CcSEcCtD
Abacavir—Malaise—Etoposide—uterine cancer	0.000828	0.00161	CcSEcCtD
Abacavir—Vertigo—Etoposide—uterine cancer	0.000825	0.0016	CcSEcCtD
Abacavir—Leukopenia—Etoposide—uterine cancer	0.000822	0.00159	CcSEcCtD
Abacavir—Body temperature increased—Dactinomycin—uterine cancer	0.000819	0.00159	CcSEcCtD
Abacavir—Abdominal pain—Dactinomycin—uterine cancer	0.000819	0.00159	CcSEcCtD
Abacavir—Lethargy—Doxorubicin—uterine cancer	0.000807	0.00156	CcSEcCtD
Abacavir—Cough—Etoposide—uterine cancer	0.000802	0.00155	CcSEcCtD
Abacavir—Blood creatinine increased—Epirubicin—uterine cancer	0.000801	0.00155	CcSEcCtD
Abacavir—Convulsion—Etoposide—uterine cancer	0.000796	0.00154	CcSEcCtD
Abacavir—Liver function test abnormal—Epirubicin—uterine cancer	0.000789	0.00153	CcSEcCtD
Abacavir—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000789	0.00153	CcSEcCtD
Abacavir—Abdominal pain upper—Epirubicin—uterine cancer	0.000781	0.00151	CcSEcCtD
Abacavir—Migraine—Doxorubicin—uterine cancer	0.000779	0.00151	CcSEcCtD
Abacavir—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000777	0.00151	CcSEcCtD
Abacavir—Discomfort—Etoposide—uterine cancer	0.000773	0.0015	CcSEcCtD
Abacavir—Toxic epidermal necrolysis—Epirubicin—uterine cancer	0.00077	0.00149	CcSEcCtD
Abacavir—Aspartate aminotransferase increased—Epirubicin—uterine cancer	0.00077	0.00149	CcSEcCtD
Abacavir—Hypersensitivity—Dactinomycin—uterine cancer	0.000763	0.00148	CcSEcCtD
Abacavir—Gastritis—Epirubicin—uterine cancer	0.000757	0.00147	CcSEcCtD
Abacavir—Muscular weakness—Epirubicin—uterine cancer	0.000754	0.00146	CcSEcCtD
Abacavir—Alanine aminotransferase increased—Epirubicin—uterine cancer	0.000754	0.00146	CcSEcCtD
Abacavir—Anaphylactic shock—Etoposide—uterine cancer	0.00075	0.00145	CcSEcCtD
Abacavir—Infection—Etoposide—uterine cancer	0.000745	0.00144	CcSEcCtD
Abacavir—Asthenia—Dactinomycin—uterine cancer	0.000743	0.00144	CcSEcCtD
Abacavir—Blood creatinine increased—Doxorubicin—uterine cancer	0.000741	0.00144	CcSEcCtD
Abacavir—Thrombocytopenia—Etoposide—uterine cancer	0.000734	0.00142	CcSEcCtD
Abacavir—ADK—Nucleotide metabolism—RRM2—uterine cancer	0.000734	0.0786	CbGpPWpGaD
Abacavir—Liver function test abnormal—Doxorubicin—uterine cancer	0.00073	0.00142	CcSEcCtD
Abacavir—Skin disorder—Etoposide—uterine cancer	0.000728	0.00141	CcSEcCtD
Abacavir—Pancreatitis—Epirubicin—uterine cancer	0.000724	0.0014	CcSEcCtD
Abacavir—Abdominal pain upper—Doxorubicin—uterine cancer	0.000723	0.0014	CcSEcCtD
Abacavir—Anorexia—Etoposide—uterine cancer	0.000715	0.00138	CcSEcCtD
Abacavir—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	0.000712	0.00138	CcSEcCtD
Abacavir—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.000712	0.00138	CcSEcCtD
Abacavir—Bronchitis—Epirubicin—uterine cancer	0.000711	0.00138	CcSEcCtD
Abacavir—Diarrhoea—Dactinomycin—uterine cancer	0.000709	0.00137	CcSEcCtD
Abacavir—Hypotension—Etoposide—uterine cancer	0.0007	0.00136	CcSEcCtD
Abacavir—Gastritis—Doxorubicin—uterine cancer	0.0007	0.00136	CcSEcCtD
Abacavir—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.000698	0.00135	CcSEcCtD
Abacavir—Muscular weakness—Doxorubicin—uterine cancer	0.000698	0.00135	CcSEcCtD
Abacavir—Neutropenia—Epirubicin—uterine cancer	0.000691	0.00134	CcSEcCtD
Abacavir—Paraesthesia—Etoposide—uterine cancer	0.000673	0.0013	CcSEcCtD
Abacavir—Pancreatitis—Doxorubicin—uterine cancer	0.00067	0.0013	CcSEcCtD
Abacavir—Dyspnoea—Etoposide—uterine cancer	0.000668	0.0013	CcSEcCtD
Abacavir—ADH6—Biological oxidations—CYP11A1—uterine cancer	0.000667	0.0715	CbGpPWpGaD
Abacavir—Hyperglycaemia—Epirubicin—uterine cancer	0.000667	0.00129	CcSEcCtD
Abacavir—Pneumonia—Epirubicin—uterine cancer	0.000663	0.00128	CcSEcCtD
Abacavir—Vomiting—Dactinomycin—uterine cancer	0.000659	0.00128	CcSEcCtD
Abacavir—Bronchitis—Doxorubicin—uterine cancer	0.000658	0.00127	CcSEcCtD
Abacavir—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.000653	0.00127	CcSEcCtD
Abacavir—Rash—Dactinomycin—uterine cancer	0.000653	0.00127	CcSEcCtD
Abacavir—Decreased appetite—Etoposide—uterine cancer	0.000652	0.00126	CcSEcCtD
Abacavir—Renal failure—Epirubicin—uterine cancer	0.000648	0.00126	CcSEcCtD
Abacavir—Gastrointestinal disorder—Etoposide—uterine cancer	0.000647	0.00125	CcSEcCtD
Abacavir—Fatigue—Etoposide—uterine cancer	0.000646	0.00125	CcSEcCtD
Abacavir—Neuropathy peripheral—Epirubicin—uterine cancer	0.000646	0.00125	CcSEcCtD
Abacavir—Stomatitis—Epirubicin—uterine cancer	0.000642	0.00124	CcSEcCtD
Abacavir—Pain—Etoposide—uterine cancer	0.000641	0.00124	CcSEcCtD
Abacavir—Conjunctivitis—Epirubicin—uterine cancer	0.00064	0.00124	CcSEcCtD
Abacavir—Neutropenia—Doxorubicin—uterine cancer	0.000639	0.00124	CcSEcCtD
Abacavir—Hepatobiliary disease—Epirubicin—uterine cancer	0.000623	0.00121	CcSEcCtD
Abacavir—Feeling abnormal—Etoposide—uterine cancer	0.000618	0.0012	CcSEcCtD
Abacavir—Hyperglycaemia—Doxorubicin—uterine cancer	0.000617	0.0012	CcSEcCtD
Abacavir—Nausea—Dactinomycin—uterine cancer	0.000615	0.00119	CcSEcCtD
Abacavir—Pneumonia—Doxorubicin—uterine cancer	0.000613	0.00119	CcSEcCtD
Abacavir—Gastrointestinal pain—Etoposide—uterine cancer	0.000613	0.00119	CcSEcCtD
Abacavir—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.000604	0.00117	CcSEcCtD
Abacavir—Renal failure—Doxorubicin—uterine cancer	0.000599	0.00116	CcSEcCtD
Abacavir—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000598	0.00116	CcSEcCtD
Abacavir—Urticaria—Etoposide—uterine cancer	0.000596	0.00115	CcSEcCtD
Abacavir—Stomatitis—Doxorubicin—uterine cancer	0.000594	0.00115	CcSEcCtD
Abacavir—Abdominal pain—Etoposide—uterine cancer	0.000593	0.00115	CcSEcCtD
Abacavir—Body temperature increased—Etoposide—uterine cancer	0.000593	0.00115	CcSEcCtD
Abacavir—Conjunctivitis—Doxorubicin—uterine cancer	0.000593	0.00115	CcSEcCtD
Abacavir—Hepatitis—Epirubicin—uterine cancer	0.000591	0.00115	CcSEcCtD
Abacavir—Pharyngitis—Epirubicin—uterine cancer	0.000587	0.00114	CcSEcCtD
Abacavir—Connective tissue disorder—Epirubicin—uterine cancer	0.000581	0.00113	CcSEcCtD
Abacavir—Hepatobiliary disease—Doxorubicin—uterine cancer	0.000577	0.00112	CcSEcCtD
Abacavir—Erythema multiforme—Epirubicin—uterine cancer	0.000559	0.00108	CcSEcCtD
Abacavir—Hypersensitivity—Etoposide—uterine cancer	0.000552	0.00107	CcSEcCtD
Abacavir—Hepatitis—Doxorubicin—uterine cancer	0.000547	0.00106	CcSEcCtD
Abacavir—Pharyngitis—Doxorubicin—uterine cancer	0.000543	0.00105	CcSEcCtD
Abacavir—Asthenia—Etoposide—uterine cancer	0.000538	0.00104	CcSEcCtD
Abacavir—Connective tissue disorder—Doxorubicin—uterine cancer	0.000538	0.00104	CcSEcCtD
Abacavir—Immune system disorder—Epirubicin—uterine cancer	0.000534	0.00104	CcSEcCtD
Abacavir—Chills—Epirubicin—uterine cancer	0.000531	0.00103	CcSEcCtD
Abacavir—Pruritus—Etoposide—uterine cancer	0.00053	0.00103	CcSEcCtD
Abacavir—Alopecia—Epirubicin—uterine cancer	0.000523	0.00101	CcSEcCtD
Abacavir—Erythema multiforme—Doxorubicin—uterine cancer	0.000517	0.001	CcSEcCtD
Abacavir—Malnutrition—Epirubicin—uterine cancer	0.000515	0.000998	CcSEcCtD
Abacavir—Diarrhoea—Etoposide—uterine cancer	0.000513	0.000994	CcSEcCtD
Abacavir—Dizziness—Etoposide—uterine cancer	0.000496	0.000961	CcSEcCtD
Abacavir—Immune system disorder—Doxorubicin—uterine cancer	0.000494	0.000958	CcSEcCtD
Abacavir—ADH6—Biological oxidations—CYP19A1—uterine cancer	0.000491	0.0526	CbGpPWpGaD
Abacavir—Chills—Doxorubicin—uterine cancer	0.000491	0.000952	CcSEcCtD
Abacavir—Alopecia—Doxorubicin—uterine cancer	0.000484	0.000937	CcSEcCtD
Abacavir—Ill-defined disorder—Epirubicin—uterine cancer	0.000478	0.000926	CcSEcCtD
Abacavir—Vomiting—Etoposide—uterine cancer	0.000477	0.000924	CcSEcCtD
Abacavir—Malnutrition—Doxorubicin—uterine cancer	0.000476	0.000923	CcSEcCtD
Abacavir—Anaemia—Epirubicin—uterine cancer	0.000476	0.000922	CcSEcCtD
Abacavir—Rash—Etoposide—uterine cancer	0.000473	0.000916	CcSEcCtD
Abacavir—Dermatitis—Etoposide—uterine cancer	0.000472	0.000915	CcSEcCtD
Abacavir—Headache—Etoposide—uterine cancer	0.00047	0.00091	CcSEcCtD
Abacavir—Malaise—Epirubicin—uterine cancer	0.000464	0.0009	CcSEcCtD
Abacavir—Vertigo—Epirubicin—uterine cancer	0.000463	0.000897	CcSEcCtD
Abacavir—Leukopenia—Epirubicin—uterine cancer	0.000461	0.000893	CcSEcCtD
Abacavir—Cough—Epirubicin—uterine cancer	0.000449	0.000871	CcSEcCtD
Abacavir—Convulsion—Epirubicin—uterine cancer	0.000446	0.000865	CcSEcCtD
Abacavir—Nausea—Etoposide—uterine cancer	0.000445	0.000863	CcSEcCtD
Abacavir—Ill-defined disorder—Doxorubicin—uterine cancer	0.000442	0.000857	CcSEcCtD
Abacavir—Anaemia—Doxorubicin—uterine cancer	0.00044	0.000853	CcSEcCtD
Abacavir—Arthralgia—Epirubicin—uterine cancer	0.000438	0.00085	CcSEcCtD
Abacavir—Myalgia—Epirubicin—uterine cancer	0.000438	0.00085	CcSEcCtD
Abacavir—Anxiety—Epirubicin—uterine cancer	0.000437	0.000847	CcSEcCtD
Abacavir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000435	0.000844	CcSEcCtD
Abacavir—Discomfort—Epirubicin—uterine cancer	0.000433	0.000839	CcSEcCtD
Abacavir—Malaise—Doxorubicin—uterine cancer	0.00043	0.000833	CcSEcCtD
Abacavir—Vertigo—Doxorubicin—uterine cancer	0.000428	0.00083	CcSEcCtD
Abacavir—Leukopenia—Doxorubicin—uterine cancer	0.000426	0.000827	CcSEcCtD
Abacavir—Oedema—Epirubicin—uterine cancer	0.00042	0.000814	CcSEcCtD
Abacavir—Anaphylactic shock—Epirubicin—uterine cancer	0.00042	0.000814	CcSEcCtD
Abacavir—Infection—Epirubicin—uterine cancer	0.000417	0.000809	CcSEcCtD
Abacavir—Cough—Doxorubicin—uterine cancer	0.000416	0.000806	CcSEcCtD
Abacavir—Convulsion—Doxorubicin—uterine cancer	0.000413	0.0008	CcSEcCtD
Abacavir—Nervous system disorder—Epirubicin—uterine cancer	0.000412	0.000799	CcSEcCtD
Abacavir—Thrombocytopenia—Epirubicin—uterine cancer	0.000411	0.000797	CcSEcCtD
Abacavir—Skin disorder—Epirubicin—uterine cancer	0.000408	0.000791	CcSEcCtD
Abacavir—Myalgia—Doxorubicin—uterine cancer	0.000406	0.000786	CcSEcCtD
Abacavir—Arthralgia—Doxorubicin—uterine cancer	0.000406	0.000786	CcSEcCtD
Abacavir—Anxiety—Doxorubicin—uterine cancer	0.000404	0.000783	CcSEcCtD
Abacavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000403	0.000781	CcSEcCtD
Abacavir—Discomfort—Doxorubicin—uterine cancer	0.000401	0.000777	CcSEcCtD
Abacavir—Anorexia—Epirubicin—uterine cancer	0.000401	0.000776	CcSEcCtD
Abacavir—Hypotension—Epirubicin—uterine cancer	0.000393	0.000761	CcSEcCtD
Abacavir—Oedema—Doxorubicin—uterine cancer	0.000389	0.000754	CcSEcCtD
Abacavir—Anaphylactic shock—Doxorubicin—uterine cancer	0.000389	0.000754	CcSEcCtD
Abacavir—Infection—Doxorubicin—uterine cancer	0.000386	0.000749	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000383	0.000742	CcSEcCtD
Abacavir—Nervous system disorder—Doxorubicin—uterine cancer	0.000381	0.000739	CcSEcCtD
Abacavir—Thrombocytopenia—Doxorubicin—uterine cancer	0.000381	0.000738	CcSEcCtD
Abacavir—Insomnia—Epirubicin—uterine cancer	0.00038	0.000737	CcSEcCtD
Abacavir—Skin disorder—Doxorubicin—uterine cancer	0.000378	0.000732	CcSEcCtD
Abacavir—Paraesthesia—Epirubicin—uterine cancer	0.000377	0.000731	CcSEcCtD
Abacavir—Dyspnoea—Epirubicin—uterine cancer	0.000375	0.000726	CcSEcCtD
Abacavir—Anorexia—Doxorubicin—uterine cancer	0.000371	0.000718	CcSEcCtD
Abacavir—Decreased appetite—Epirubicin—uterine cancer	0.000365	0.000708	CcSEcCtD
Abacavir—Hypotension—Doxorubicin—uterine cancer	0.000363	0.000704	CcSEcCtD
Abacavir—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000363	0.000703	CcSEcCtD
Abacavir—Fatigue—Epirubicin—uterine cancer	0.000362	0.000702	CcSEcCtD
Abacavir—Pain—Epirubicin—uterine cancer	0.000359	0.000696	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000354	0.000687	CcSEcCtD
Abacavir—Insomnia—Doxorubicin—uterine cancer	0.000352	0.000682	CcSEcCtD
Abacavir—Paraesthesia—Doxorubicin—uterine cancer	0.000349	0.000677	CcSEcCtD
Abacavir—Dyspnoea—Doxorubicin—uterine cancer	0.000347	0.000672	CcSEcCtD
Abacavir—Feeling abnormal—Epirubicin—uterine cancer	0.000346	0.000671	CcSEcCtD
Abacavir—Gastrointestinal pain—Epirubicin—uterine cancer	0.000344	0.000666	CcSEcCtD
Abacavir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—NFE2L2—uterine cancer	0.000342	0.0366	CbGpPWpGaD
Abacavir—Decreased appetite—Doxorubicin—uterine cancer	0.000338	0.000655	CcSEcCtD
Abacavir—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000336	0.000651	CcSEcCtD
Abacavir—Fatigue—Doxorubicin—uterine cancer	0.000335	0.00065	CcSEcCtD
Abacavir—Urticaria—Epirubicin—uterine cancer	0.000334	0.000647	CcSEcCtD
Abacavir—Pain—Doxorubicin—uterine cancer	0.000332	0.000644	CcSEcCtD
Abacavir—Abdominal pain—Epirubicin—uterine cancer	0.000332	0.000644	CcSEcCtD
Abacavir—Body temperature increased—Epirubicin—uterine cancer	0.000332	0.000644	CcSEcCtD
Abacavir—Feeling abnormal—Doxorubicin—uterine cancer	0.00032	0.000621	CcSEcCtD
Abacavir—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000318	0.000616	CcSEcCtD
Abacavir—Hypersensitivity—Epirubicin—uterine cancer	0.00031	0.0006	CcSEcCtD
Abacavir—Urticaria—Doxorubicin—uterine cancer	0.000309	0.000599	CcSEcCtD
Abacavir—Abdominal pain—Doxorubicin—uterine cancer	0.000307	0.000596	CcSEcCtD
Abacavir—Body temperature increased—Doxorubicin—uterine cancer	0.000307	0.000596	CcSEcCtD
Abacavir—Asthenia—Epirubicin—uterine cancer	0.000301	0.000584	CcSEcCtD
Abacavir—Pruritus—Epirubicin—uterine cancer	0.000297	0.000576	CcSEcCtD
Abacavir—Diarrhoea—Epirubicin—uterine cancer	0.000288	0.000557	CcSEcCtD
Abacavir—Hypersensitivity—Doxorubicin—uterine cancer	0.000286	0.000555	CcSEcCtD
Abacavir—Asthenia—Doxorubicin—uterine cancer	0.000279	0.000541	CcSEcCtD
Abacavir—Dizziness—Epirubicin—uterine cancer	0.000278	0.000539	CcSEcCtD
Abacavir—Pruritus—Doxorubicin—uterine cancer	0.000275	0.000533	CcSEcCtD
Abacavir—Vomiting—Epirubicin—uterine cancer	0.000267	0.000518	CcSEcCtD
Abacavir—Diarrhoea—Doxorubicin—uterine cancer	0.000266	0.000516	CcSEcCtD
Abacavir—Rash—Epirubicin—uterine cancer	0.000265	0.000514	CcSEcCtD
Abacavir—Dermatitis—Epirubicin—uterine cancer	0.000265	0.000513	CcSEcCtD
Abacavir—ADH6—Metabolism—SRD5A2—uterine cancer	0.000264	0.0283	CbGpPWpGaD
Abacavir—ADH6—Metabolism—NDUFB11—uterine cancer	0.000264	0.0283	CbGpPWpGaD
Abacavir—Headache—Epirubicin—uterine cancer	0.000263	0.00051	CcSEcCtD
Abacavir—Dizziness—Doxorubicin—uterine cancer	0.000257	0.000498	CcSEcCtD
Abacavir—Nausea—Epirubicin—uterine cancer	0.00025	0.000484	CcSEcCtD
Abacavir—Vomiting—Doxorubicin—uterine cancer	0.000247	0.000479	CcSEcCtD
Abacavir—Rash—Doxorubicin—uterine cancer	0.000245	0.000475	CcSEcCtD
Abacavir—Dermatitis—Doxorubicin—uterine cancer	0.000245	0.000475	CcSEcCtD
Abacavir—Headache—Doxorubicin—uterine cancer	0.000244	0.000472	CcSEcCtD
Abacavir—Nausea—Doxorubicin—uterine cancer	0.000231	0.000448	CcSEcCtD
Abacavir—ADH6—Metabolism—AKR1B1—uterine cancer	0.000191	0.0204	CbGpPWpGaD
Abacavir—ADH6—Metabolism—STAR—uterine cancer	0.000191	0.0204	CbGpPWpGaD
Abacavir—UGT1A1—Metapathway biotransformation—AKR1B10—uterine cancer	0.000187	0.02	CbGpPWpGaD
Abacavir—UGT1A1—Metapathway biotransformation—AKR1B1—uterine cancer	0.000174	0.0186	CbGpPWpGaD
Abacavir—ADH6—Metabolism—POLD1—uterine cancer	0.00015	0.016	CbGpPWpGaD
Abacavir—ADK—Metabolism—NDUFB11—uterine cancer	0.000141	0.0151	CbGpPWpGaD
Abacavir—ADK—Metabolism—SRD5A2—uterine cancer	0.000141	0.0151	CbGpPWpGaD
Abacavir—ADH6—Metabolism—AKR1C1—uterine cancer	0.00014	0.015	CbGpPWpGaD
Abacavir—UGT1A1—NRF2 pathway—NFE2L2—uterine cancer	0.000136	0.0145	CbGpPWpGaD
Abacavir—UGT1A1—NRF2 pathway—GPX3—uterine cancer	0.000129	0.0139	CbGpPWpGaD
Abacavir—UGT1A1—Metapathway biotransformation—AKR1C1—uterine cancer	0.000128	0.0137	CbGpPWpGaD
Abacavir—ADH6—Metabolism—RRM2—uterine cancer	0.000125	0.0134	CbGpPWpGaD
Abacavir—ADH6—Metabolism—DCN—uterine cancer	0.000121	0.013	CbGpPWpGaD
Abacavir—ADH6—Metabolism—CYP11A1—uterine cancer	0.000114	0.0122	CbGpPWpGaD
Abacavir—UGT1A1—Metapathway biotransformation—GPX3—uterine cancer	0.000112	0.012	CbGpPWpGaD
Abacavir—ADH6—Metabolism—AKR1C3—uterine cancer	0.000108	0.0115	CbGpPWpGaD
Abacavir—UGT1A1—Biological oxidations—CYP11A1—uterine cancer	0.000105	0.0113	CbGpPWpGaD
Abacavir—UGT1A1—Metapathway biotransformation—CYP11A1—uterine cancer	0.000104	0.0111	CbGpPWpGaD
Abacavir—ADK—Metabolism—STAR—uterine cancer	0.000102	0.0109	CbGpPWpGaD
Abacavir—ADK—Metabolism—AKR1B1—uterine cancer	0.000102	0.0109	CbGpPWpGaD
Abacavir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—CDKN1B—uterine cancer	0.000101	0.0108	CbGpPWpGaD
Abacavir—UGT1A1—Metapathway biotransformation—AKR1C3—uterine cancer	9.82e-05	0.0105	CbGpPWpGaD
Abacavir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EP300—uterine cancer	8.88e-05	0.00951	CbGpPWpGaD
Abacavir—ADH6—Metabolism—STK11—uterine cancer	8.4e-05	0.00899	CbGpPWpGaD
Abacavir—ADH6—Metabolism—CYP19A1—uterine cancer	8.4e-05	0.00899	CbGpPWpGaD
Abacavir—ADK—Metabolism—POLD1—uterine cancer	7.99e-05	0.00856	CbGpPWpGaD
Abacavir—UGT1A1—Biological oxidations—CYP19A1—uterine cancer	7.76e-05	0.00831	CbGpPWpGaD
Abacavir—UGT1A1—Metapathway biotransformation—CYP19A1—uterine cancer	7.65e-05	0.00819	CbGpPWpGaD
Abacavir—ADK—Metabolism—AKR1C1—uterine cancer	7.48e-05	0.00801	CbGpPWpGaD
Abacavir—ADK—Metabolism—RRM2—uterine cancer	6.66e-05	0.00714	CbGpPWpGaD
Abacavir—ADK—Metabolism—DCN—uterine cancer	6.47e-05	0.00693	CbGpPWpGaD
Abacavir—ADH6—Metabolism—MTHFR—uterine cancer	6.31e-05	0.00676	CbGpPWpGaD
Abacavir—ADK—Metabolism—CYP11A1—uterine cancer	6.09e-05	0.00653	CbGpPWpGaD
Abacavir—ADK—Metabolism—AKR1C3—uterine cancer	5.76e-05	0.00616	CbGpPWpGaD
Abacavir—ADK—Metabolism—STK11—uterine cancer	4.48e-05	0.0048	CbGpPWpGaD
Abacavir—ADK—Metabolism—CYP19A1—uterine cancer	4.48e-05	0.0048	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—NDUFB11—uterine cancer	4.17e-05	0.00446	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—SRD5A2—uterine cancer	4.17e-05	0.00446	CbGpPWpGaD
Abacavir—ADH6—Metabolism—PTEN—uterine cancer	3.51e-05	0.00376	CbGpPWpGaD
Abacavir—ADK—Metabolism—MTHFR—uterine cancer	3.37e-05	0.00361	CbGpPWpGaD
Abacavir—ADH6—Metabolism—EP300—uterine cancer	3.35e-05	0.00359	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—AKR1B1—uterine cancer	3.01e-05	0.00323	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—STAR—uterine cancer	3.01e-05	0.00323	CbGpPWpGaD
Abacavir—ADH6—Metabolism—PIK3CA—uterine cancer	2.48e-05	0.00265	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—POLD1—uterine cancer	2.36e-05	0.00253	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—AKR1C1—uterine cancer	2.21e-05	0.00237	CbGpPWpGaD
Abacavir—ADH6—Metabolism—AKT1—uterine cancer	2.02e-05	0.00217	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—RRM2—uterine cancer	1.97e-05	0.00211	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—DCN—uterine cancer	1.91e-05	0.00205	CbGpPWpGaD
Abacavir—ADK—Metabolism—PTEN—uterine cancer	1.87e-05	0.00201	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—CYP11A1—uterine cancer	1.8e-05	0.00193	CbGpPWpGaD
Abacavir—ADK—Metabolism—EP300—uterine cancer	1.79e-05	0.00191	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—AKR1C3—uterine cancer	1.7e-05	0.00182	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—CYP19A1—uterine cancer	1.33e-05	0.00142	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—STK11—uterine cancer	1.33e-05	0.00142	CbGpPWpGaD
Abacavir—ADK—Metabolism—PIK3CA—uterine cancer	1.32e-05	0.00142	CbGpPWpGaD
Abacavir—ADK—Metabolism—AKT1—uterine cancer	1.08e-05	0.00116	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—MTHFR—uterine cancer	9.97e-06	0.00107	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—PTEN—uterine cancer	5.55e-06	0.000594	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—EP300—uterine cancer	5.29e-06	0.000566	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—PIK3CA—uterine cancer	3.91e-06	0.000419	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—AKT1—uterine cancer	3.2e-06	0.000342	CbGpPWpGaD
